Latest on Pharmaceutical Industry


Octapharma announces approval of new concentrations of the Nuwiq® product in Europe, increasing dosage flexibility for patients with hemophilia A

Octapharma today announced that the European Medicines Agency (EMA) has approved an extension of the marketing authorization for its recombinant factor VIII product (rFVIII) derived from the human cell line, Nuwiq ® . T..Read More...

Roche to pay $2.4 billion to buy rest of Foundation Medicine

Roche Holding AG has agreed to pay $137 per share to buy the rest of Foundation Medicine (FMI), valuing the U.S. genomic profiling group at $5.3 billion, the partners said on Tuesday. The deal, backed by the boards of..Read More...



International Conference On Pharmacology

Hilton Narita Tokyo,
Meetings International Pte. Ltd


pharmaceutical packaging and labelling 2018


Press Releases

Mylan Launches Generic Angiomax® Injection

Global pharmaceutical company Mylan NV today announced the US launch of Bivalirudin for Injection 250 mg singledose vial a generic version of Angiomax from The Medicines Company The product is a direct thrombin inhibitor.. Read More...

Shamrock Biopharmaceuticals Launches the First Patient of the SCB-313 Malignant Ascites Clinical Trial in Australia

Shamrock Biopharmaceutical a biopharmaceutical company committed to the development of innovative and transformative biopharmaceuticals today announced the first patient in the SCB313 Phase I clinical trial in Australia .. Read More...

Suppliers of the Month

Product Launch



Latest Reports


Latest Projects


Expert Talk

Aurena Laboratories AB

Aurena Laboratories AB Aurena business model is to offer support brand owners to launch innovative and competitive products with shortest possible time to market We produce the product to companies around the world. Read More...
Magnus Hedman
Director Business Development Marketing